| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, SUNY/Downstate Medical Center, Brooklyn, New York.
Abstract
Bolus injections of succinylcholine (1.5 mg/kg) significantly increased intracranial pressure (ICP) in cats under normal conditions from control levels of 8 ± 1 mm Hg to 16 ± 3 mm Hg (± SEM, P < 0.01), and in the presence of artificially increased ICP from control levels of 27 ± 1 mm Hg to 47 ± 4 mm Hg (P < 0.01). These approximately 100% increases in ICP were accompanied by a transitory decrease in mean arterial pressure (approximately 10 sec), followed by a 15–20% increase (P < 0.05). Pulmonary arterial pressure increased 20–30% (P < 0.05). These results, when considered in conjunction with results previously obtained in humans, suggest that succinylcholine may be contraindicated in neurosurgical patients.
Key Words: CEREBROSPINAL FLUID: pressure NEUROMUSCULAR RELAXANTS: succinylcholine
This article has been cited by other articles:
![]() |
M Clancy, S Halford, R Walls, and M Murphy In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review Emerg. Med. J., September 1, 2001; 18(5): 373 - 375. [Abstract] [Full Text] [PDF] |
||||
|